Product image of Xevudy (Sotrovimab) supplied by GNH India

Xevudy

Active Ingredient:
Sotrovimab
Origin:
EU

Xevudy (Sotrovimab)

Xevudy (sotrovimab) is an antiviral medication used to treat mild-to-moderate COVID-19 in adults and children. It is designed to reduce the risk of severe disease progression. This product is administered via intravenous infusion under medical supervision.

Manufacturer / TM Owner

Glaxosmithkline Trading Services Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Xevudy is primarily used for the treatment of mild-to-moderate COVID-19 in patients who are at high risk of progressing to severe disease. It may also be considered for post-exposure prophylaxis in certain cases. The medication works by binding to the spike protein of the SARS-CoV-2 virus, helping to neutralize its effects. It is not a substitute for vaccination.

Side Effects

  • Xevudy is designed to reduce viral load and may help alleviate symptoms associated with COVID-19. Patients may experience a decrease in fever, cough, and fatigue as the medication takes effect. The onset of action varies by individual, and full benefits may require several days to become apparent.

Precautions & Warnings

  • Xevudy should only be administered by healthcare professionals in a clinical setting equipped for intravenous therapy. Patients with a history of severe allergic reactions to monoclonal antibodies should inform their provider. Monitoring for infusion-related reactions is recommended during and after administration.

Avoid Interactions

  • Limited data exist on drug interactions with sotrovimab. However, as a monoclonal antibody, it is unlikely to interact with other medications metabolized by the liver. Caution is advised when co-administering with other antiviral or immunomodulatory therapies. Always disclose all medications to your healthcare provider.

Frequently Asked Questions

Xevudy is used to treat mild-to-moderate COVID-19 in adults and children at high risk of severe disease progression.

Xevudy is given as a single-dose intravenous infusion by a healthcare professional.

Xevudy may be considered for post-exposure prophylaxis in certain high-risk individuals, but it is not a vaccine substitute.

Common side effects may include infusion-related reactions, fever, or nausea.

No, Xevudy requires a prescription and must be administered by a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sotrovimab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT